Lucira Health to Announce Second Quarter 2021 Financial Results
July 29 2021 - 07:00AM
Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits,
today announced that the company will report second quarter 2021
financial results on, Thursday, August 12, 2021. Lucira’s
management will host a conference call and webcast at 1:30 p.m. PT
/ 4:30 p.m. ET that day to discuss the financial results and
provide a corporate update.
Conference Call and Webcast DetailsThe
conference call can be accessed by dialing (833) 562-0151 for
participants in the U.S. or Canada and (661) 567-1232 for
international callers, using conference ID 4241018. A live and
archived webcast of the event can be accessed through the following
link ir.lucirahealth.com.
About Lucira Health, Inc. Lucira is a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits.
Lucira’s testing platform produces PCR quality molecular testing in
a single-use, consumer-friendly, palm-size test kit powered by two
AA batteries. Lucira designed its test kits to provide accurate,
reliable and on-the-spot molecular test results anywhere and at any
time. The LUCIRA™ CHECK IT COVID-19 Test Kit (OTC) and LUCIRA™
COVID-19 All-In-One Test Kit (Rx) provide PCR quality clinically
relevant COVID-19 result within 30 minutes from sample
collection. Lucira’s CHECK IT (OTC) also provides a SMS
verified digital LUCI PASS test result back to a user’s phone for
work, travel and other places where negative test verification may
be required.
Investor Contact Greg Chodaczek
Investorrelations@lucirahealth.com347-620-7010
Media Contact Kevin Knight
media@lucirahealth.com 206-451-4823
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Mar 2023 to Mar 2024